1/60
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
how does genetic recomb of BCR regions occur
HC, VDJ → RSS + RAG1/2 → Hairpin + artemis → P + exonucleotides → TdT + N →
P, N nucleotides, and exonuclease activity
additional mechs for diversity
P nucleotides
palindromic nucleotides
generated when Artemis cleaves hairpin
N nucleotides
non-templated random nucleotides
added by TdT to open strands of DNA
after Artemis cleaves
exonuclease activity
removes nucleotide form ssDNA
results after Artemis cleavage
BCR HC
single
use J,D,V
P and N nucleotides
TdT
BCR LC
kappa and lambda
V and J
order of BCR expression
Generate HC
pre-BCR stability w/ SLC
test w/ kappa LC → Lambda LC if both kappas dont work
allelic exculsion = chain expression order (HC → KC → LC) and expression of one alleles for each chain
autoreactive BCR
induce further LC V,J rearrangement
mRNA can generate how many different antibodies from what
4 from a single RNA transcript
IgM and D
splicing
can select either IgM (u) or IgD (S) constant regions
determines if BCR is mem bound or secreted
future gene DNA recomb = dif AB classes
BCR and TCR
hc → VDJ → RSS, RAG1/2 → artemis → P → exo → TdT → N → chain testing
BCR
HC and LC
Surrogate LC
mRNA splicing
TCR
HC = Beta, Delta
LC = alpha, gamma
± selection
MHC I
expressed by most cells
cytoplasmic Ag 8-10 aa
binding cleft = 1 a chain
B2 microglobulin
CD8
Tc
req cytosolic/endogenous processing
immunoproteasome
TAP
MHC II
expressed by APCs
13-18 aa
binding cleft = 2 chains a/B
CD4 Th
extracellular Ag
presentation req exogenous processing
invariant chain
cross presentation
results in MHC I presentation of extracellular peptide by dend cell
MHC I and II
both present pathogen and self peptides
encoded w/in MHC locus
encoded by multiple genes w/ mutated binding sites
involved w/ B cells
secretes cytokines
detects MHC on thymus epithelial cells
antigen loading pathway MHC I
TAP: transports Ag into RER
B2 microglobulin: on RER
ER
immunoproteasome: cleaves Ag for better MHC binding
MHC I + peptide
antigen loading pathway MHC II
phagocytosed protein
invariant chain blocked MHC II ER → endosome → degraded chain
MHC II + peptide
influence factors of MHC expression
PRR-Stimulated transcription
cytokine stimulate transcription
viral inhibition
CD1 and MR1
present non-peptide antigens to TCR
MHC polymorphisms and Haplotypes
anchor residues w/in binding pockets = presented peptides
mutation w/in binding site (poly) = new MHC (haplo)
MHC present dif peptides = simultaneously expressed
transplantation of dif MHC lead to rejection
why transplantation of dif MHC lead to rejection
if MHC dont match they will reject and see the transplant as anti self
order of TCR expression testing
B chain + pre Ta → Pre-TCR
test for CD3 signaling
a chain → expressed CD4/8
testing
+ selection
TCR interacts w/ particular MHC
non-binding cells = anergy = death 95%
- selection
TCR doesn’t interact w/ MHC and self too strongly
too strong = autoimmunity
non-central tolerance
Treg cells
peripherial tolerance
Treg cells
arise from TCR binding self peptides but not too strongly
depletes cytokines
produce inhibitoy cytokines
inhibit APC
kills T cells
peripheral tolerance
not accompanied by other signals prevent T cell activation
lineage commitment mechs
instructive
stochastic
kinetic
instructive
it knows
depends on which MHC DP cells interact w/ more strongly
stochastic
random, it doesnt know
either CD4 or 8 downgraded and + = cell survival - = cell death
kinetic
it doesn’t know but tests both
one is tested and if no response other is tested
- selection in the medulla
cells tested on dend cells and mTECs
both express MHC I and II
tests both types of cells
mTEC
express AIRE regulator = other tissue presentation for - selection (skin)
NKT cells
CD4 or DN
cannot develop mem cells
express TCR interacts w/ lipid presenting MHC CD1
secrete cytokines and kills cells
gamma delta (yS) Tcells
DN for CD4/8
less TCR diversity
detects lipids like NKT
process of naive T cell activation by dend cells
3 signals for activation
cross presentation for Tc
signal 1
TCR CD3 and CD4 or 8 contact w/ peptide + MHC
signal 2
CD28 binding w/ CD 80/86
if missing = clonal anergy
signal 3
cytokines from dend cell in response to PRR = dif into effector cells
superantigens subvertion
antigen that binds on the side and not in the MHC pocket so no ID = body throws everything at it in an attempt to kill the unknown
can lead to T cell activation/cytokine storms
detrimental in infections and autoimmunity
CTLA-4 subvertion
a negative receptor, regulated T cell activity
maintains homeostasis
if blocked = T cell overstimulation = possible autoimmune diseases
T cell activation outcomes
increased proliferation, IL-2
increased diff, generation of mem cells at each diff step
final diff into effector cells through activation of master regulators
Th1
intracellular
increase macrophage, enhance phagocytosis/MHCII → increased Tc activation
Bs switch from IgM/D → IgG, better against intracellular pathogens
IFN-y
Th2
extracellular (IL-4, 5, 13)
IL-4: Bs → IgE fro allergic response
increase antibodies and granulocytes
fights parasites/allergens
Treg
anti-immune response
low inflammation
Th17
extracellular
high inflammation
Th9
extracellular
cancer autoimmunity
Th22
extracellular
skin
TFH
activate B cells w/in secondary lymphoid organ follicles
naive Tc require
same three signals as Th
TCR/MHC-I
CD28, CD 80/86
cytokines
Th activation req first, dend cel cross-presentation to MHC I
CTL mech to kill infected cells
perforin/granzyme
Fas/FasL
Th and Tc dif class similarities
Th and Tc memory formation
NKT and what they sense
how NK know a cell is compromised
how NK and NKT respond to activation
mem T cells
occur at each step on dif pathway
localize:
central cells
localized: